Discussing investor engagement and IR strategy in global markets at Japan’s largest CFO conference*
IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced that Yuya Yoshida, Director, Chief Financial Officer (CFO) and Chief Operating Officer (COO), will speak at “CFO LEADERS SUMMIT 2026,” to be held on Sunday, November 15, 2026, at Tokyo International Forum in Chiyoda City, Tokyo. The event is organized by CPA Excellent Partners Co., Ltd., based in Shinjuku, Tokyo.
“CFO LEADERS SUMMIT 2026” is a conference focused on the CFO function, which the organizer positions as Japan’s largest*. The event brings together more than 80 leading speakers across 20 sessions. Aimed at CFOs, executives, and aspiring CFOs, the conference explores the expanding role of the CFO, spanning strategy, investor relations, M&A, and organization, as well as the future of management and finance.
At the event, Mr. Yoshida will speak in the official session “Investor and IR Strategies in Global Markets.” With AI-driven innovation intensifying competition among companies, growth strategies, and the way they are communicated to investors, require constant updating. As CFO of a Nasdaq-listed company, Mr. Yoshida will discuss IR strategy and investor engagement in international markets with three other speakers.
*Source: Official website of “CFO LEADERS SUMMIT 2026” (organizer’s description)
Overview of “CFO LEADERS SUMMIT 2026”
Date and time: Sunday, November 15, 2026, 12:30 p.m. to 6:45 p.m. (JST)
Organizer: CPA Excellent Partners Co., Ltd.
Venue: Tokyo International Forum, Halls B7 & B5 (Chiyoda City, Tokyo)
Official website: https://cpass-net.jp/cfo-leaders-summit/#cc-event
Note: Attendance requires advance registration (ticket purchase) through the official website.
Session Details
Session title: Investor and IR Strategies in Global Markets
Date and time: Sunday, November 15, 2026, 2:40 p.m. to 3:30 p.m. (JST)
Room: Hall B7, Booth D
Note: After the session, attendees will be able to interact with the speakers in the networking space.
About Yuya Yoshida
In 2003, he joined Mitsubishi UFJ Financial Group, covering market operations, securitization, M&A, and ALM/treasury functions, and earned an MBA from the UCLA Anderson School of Management in 2014. From 2016 to 2023, he served as Global Head and Director of Corporate Development at Rakuten Group, Inc., leading M&A, investments, and business alliances. He has served as Chief Operating Officer and a member of the Board of Directors of SBC Medical Group Holdings Incorporated since September 2023, and as Chief Financial Officer of the Company and SBC Medical Group Co., Ltd. (Japan) since April 2025. He now leads the group-wide AI transformation (AIX) and drives the Longevity strategy as Head of SBC AI Lab and Chief AI Evangelist, and as CEO of SBC AI Longevity Innovation, Inc.
About SBC Medical Group Holdings Incorporated
SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release, and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp